Peak6 LLC Novo Cure LTD Transaction History
Peak6 LLC
- $45.9 Billion
- Q4 2024
A detailed history of Peak6 LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Peak6 LLC holds 79,400 shares of NVCR stock, worth $1.72 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,400Holding current value
$1.72 Million% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$255 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$192 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$104 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$59.3 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.27B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...